Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 13Gastrointestinal 9CNS 7Other hematologic neoplasm 4Myeloid 3Gynecologic 3Genitourinary 3Breast 3Thoracic 2Plasma cell 2Lymphoid 2Sarcoma 1Other solid neoplasm 1Head & Neck 1

Conditions

Ovarian Neoplasms 2Hematologic Neoplasms 1Endometrial Neoplasms 1Colonic Neoplasms 1Basal Cell Nevus Syndrome 1

Interventions

Paclitaxel 581Carboplatin 528Cisplatin 359Bevacizumab 256pembrolizumab 228Gemcitabine 157liposomal doxorubicin 132Topotecan 131olaparib 129Cyclophosphamide 128Radiotherapy 118Taxes 114Docetaxel 95Brachytherapy 94Drug Therapy 91niraparib 88Doxorubicin 86Surveys and Questionnaires 85Magnetic Resonance Spectroscopy 80Blood Specimen Collection 74Nivolumab 71Specimen Handling 70Hyperthermic Intraperitoneal Chemotherapy 64Biopsy 63fludarabine 57Filgrastim 53Letrozole 50Oxaliplatin 49durvalumab 47Immunoglobulin G 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
sonidegib × Gynecologic × Clear all
NCT02195973 2026-02-09

Phase IB Trial of LDE225 and Paclitaxel in Recurrent Ovarian Cancer

University of Alabama at Birmingham

Phase 1 Completed
15 enrolled
Gynecologic

Ovarian Neoplasms

NCT01954355 2019-12-06

LDE225 and Paclitaxel in Solid Tumors

Swiss Cancer Institute

Phase 1 Completed
30 enrolled
Gynecologic

Ovarian Neoplasms

NCT02002689 2016-05-02

SIGNATURE

Novartis

Phase 2 Terminated
10 enrolled 9 charts
DermatologicGastrointestinalGynecologicOther hematologic neoplasm

Basal Cell Nevus Syndrome, Colonic Neoplasms, Endometrial Neoplasms, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡